Rotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?
|
|
- Chrystal Fowler
- 6 years ago
- Views:
Transcription
1 Disclosure Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Fractyl laboratories, Inc Anuja Dokras, MD., Ph.D. Professor of Obstetrics and Gynecology Director PENN PCOS Program University of Pennsylvania Rotterdam Criteria A Changing Paradigm in PCOS 1. Oligo-ovulation or anovulation 2. Clinical or biochemical signs of hyperandrogenism 3. Polycystic ovaries on ultrasound any two of above three (exclusion of TSH, Prolactin, 17 OH progesterone, DHEAS) Most common endocrine disorder in reproductive age 6-15% Human Reproduction Vol.19, No.1 pp , 2004 Fertil Steril 81 (2004), pp Human Reproduction 27:14-24 (2012) 1
2 PCOS in the Perimenopause PCOS n=681, controls n=230 % women with ovulatory cycles increased from 52 to 85% Age in years Carmina et al, 2012, Obstetrics and Gynecology Pinola et al, JCEM, 2015 Infertility Hirsuitism Oligomenorrhea Preeclampsia PCOS OBESITY Endometrial hyperplasia Wiser et al, RBO, 2013 Glucose intolerance Hyperlipidemia Cardiovascular disease risk 2
3 Obesity in PCOS Obesity in PCOS Adolescents OR 2.77 (95%CI ) Lin et al, HRU, 2012 Hickey et al, 2011, Hum Reprod Obesity Not Part of the Diagnosis of PCOS Abdominal Adiposity in PCOS Prevalence of abdominal adiposity in normal and overweight women Yildiz et al, JCEM, 2008 Teede et al, Obesity, 2013 Jovanovic et al. Fert Steril 2010 Aug 3
4 PCOS Impaired Glucose Tolerance Risk of Gestational Diabetes OR 2.48 ( ) Prevalence 6-35% Moran et al, 2010, Hum Reprod OR 3.58 (95% CI ) Qin et al, 2013 PCOS - Type 2 Diabetes Diabetes Risk Independent of Age and BMI HR 3.07 (95% CI ) OR 4.43 ( ) Prevalence 2-10% Moran et al, 2010, Hum Reprod Morgan et al, 2012, JCEM 4
5 Dyslipidemia - Triglycerides Dyslipidemia - HDL-C Mean difference 26.6mg/dl (95%CI ) Only 3 studies were TG >150mg/dl HDL-C is lower in PCOS by 6.41mg/dl (95%CI ) Reverse Cholesterol Transport & Efflux Cholesterol Efflux Capacity & Coronary Artery Disease Khera et al, NEJM,
6 Cholesterol Efflux Capacity and Incident Heart Disease Dallas Heart Study, According to Models Based on High-Density Lipoprotein (HDL) Cholesterol Level and Cholesterol Efflux Capacity. Rohatgi A et al. N Engl J Med 2014;371: Roe et al, 2014, JCEM Women with PCOS had an 11% decrease in normalized cholesterol efflux capacity Dyslipidemia - LDL-C Lipid Profile Overview LDL-C levels were higher by 12.6mg/dl (%95 CI ) 6
7 Lipoprotein Subclass Particles - NMR Spectroscopy Risk of Metabolic Syndrome **p<0.01, *p<0.05 Roe et al, 2014, JCEM OR 2.88 (95% CI ) Moran et al, 2010, Hum Reprod Androgen Levels and Cardiometabolic Risk Factors Metabolic Syndrome in PCOS phenotypes PCOS n=170 Normal n=170 Fauser et al, Hum Reprod
8 Impact of Race on Metabolic Risk PCOS US White US Black India Brazil Finland Norway Is PCOS a Lifetime Metabolic Disorder? * n Metabolic Syndrome 52 (28%) 52 (51.5%) BMI criterion (47.9%) (73.3%) TG criterion (20.4%) (9.9%) BP criterion (36.6%) (58.4%) Glucose criterion (11.8%) (21.8%) HDL criterion (41.4%) (71.3%) 65 (29.6%) 82 (37.3%) 59 (26.8%) 37 (16.8%) 63 (28.6%) 214 (97.3%) 70 (29.4%) 26 (27.7%) 106 (26.5%) (42%) (47.9%) (47%) (26.9%) (11.7%) (20.2%) (34.9%) (36.2%) (45.6%) (17.7%) 16 (17%) (26.1%) (59.7%) (43.6%) (56.1%) * * ** * * * * * Chan et al, AJOG, 2017 Human Reprod 2012 Sprung et al, Clin Endo
9 Coronary Artery Calcification (CAC) & PCOS Does the CVD Risk Persist in the Menopause? Author Year Shroff, 2007 Christian, 2003 Talbott, 2004 Talbott, 2008 Chang, 2011 Calderon-Margalit 2014 n 24 cases controls 36 cases 71 controls 61 cases 85 controls 149 cases 166 controls 144 PCOS 170 controls 55 PCOS 668 controls Study Population/ Study Design Outcome Measure/ Results Obese, Prevalence of CAC (>0) premenopausal OR=5.5 (1.03, 29.45) [cross-sectional] p<0.03 Premenopausal, Prevalence of CAC (>0) age OR=1.99 (0.68,5.82) [cross-sectional] p=0.21 (NS) BMI < 35 [prospective] Age Prevalence of CAC (>0) OR=2.31 (1.00, 5.33) p=0.049 All BMI Prevalence of CAC >10 [cross-sectional] OR=1.90 (1.04, 3.48) p=0.037 Age 37-45years Cross sectional Prevalence of CAC (>10) PCOS 5.4% controls 6.3% p=0.74 Mean age 45.3 Prevalence of CAC (>0) OR 2.7 ( ) 33 Coronary Artery Disease Timeline Change in Metabolic Risk over 20 years Diabetes Hypertension A, Diabetes prevalence in 2008 and 1987; B, prevalence of treated hypertension in 2008 and *, P < 0.05; **, P < 0.01; ***, P < Schmidt J et al. JCEM 2011;96:
10 Does the CVD Risk Persist in the Menopause? Perimenopause and Metabolic Syndrome SWAN n=2543, mean age 45.8years Wang et al, 2010 Obstet Gynecol Polotsky et al, 2012, JCEM Metabolic Risk after Menopause Metsyn Stroke MI Obesity and smoking were strongest predictors Patel et al, Endo care,
11 Non fatal stroke Non fatal CHD Hart et al, 2015, JCEM Oncotarget,
12 Recommendations JCEM, May 2010 Acknowledgements PENN Andrea Roe Jessica Chan Jennifer Hillman Laura Cooney Hershey Richard Legro NHLBI Nehal Mehta Martin Playford AEPCOS Society Terhi Piltonen Sujata Kar Ezster Vanky Gustavo Marciel 12
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationThe Impact of Insulin Resistance on Long-Term Health in PCOS
Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More informationCREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University
CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of
More informationAttendee become familiar with the evidence for the major risk factors for CVD Attendee will become familiar with the
PCOS Cardiovascular Health (Post( Post-Reproductive Life) Robert A. Wild, M.D., Ph.D., M.P.H Professor and Chief Gynecology Professor Clinical Epidemiology Department of Obstetrics and Gynecology VA Medical
More informationCARDIOVASCULAR RISK FACTORS. Harpal S Randeva. Warwick Medical School University of Warwick, UK
NORDIC FEDERATION OF SOCIETIES OF OBSTETRICS AND GYNAECOLOGY November, 2010 POLYCYSTIC OVARY SYNDROME THROUGH LIFE CARDIOVASCULAR RISK FACTORS Harpal S Randeva Warwick Medical School University of Warwick,
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationWhat every dermatologist should know about Polycystic Ovary Syndrome (PCOS)
What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) Kanade Shinkai, MD PhD University of California, San Francisco Associate Professor of Dermatology I have no conflicts of interest
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationCORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2
CORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2 HOW TO CITE THIS ARTICLE: Shashikala H. Gowda, Mansi Dhingra.
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationDoes PCOS Compromise the oocyte and embryo quality or the endometrium?
Does PCOS Compromise the oocyte and embryo quality or the endometrium? Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Bayer, Ogeda (Euroscreen),
More informationMetabolic changes in menopausal transition
Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More informationComparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Akshaya S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2561-2565 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationClinical Manifestations of the Polycystic Ovary Syndrome at Menopausal Age
American Journal of Medicine and Medical Sciences 2019, 9(1): 35-39 DOI: 10.5923/j.ajmms.20190901.06 Clinical Manifestations of the Polycystic Ovary Syndrome at Menopausal Age Gafurova F. A. Assistant
More informationHyperandrogenism, PCOS and obesity after menopause : Meet the experts. Polycystic ovaries beyond menopause
Hyperandrogenism, PCOS and obesity after menopause : Meet the experts Polycystic ovaries beyond menopause Serge Rozenberg CHU St Pierre Université libre de Bruxelles, Vrije Universiteit Brussel Belgium
More informationClinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
International Endocrinology Volume 2012, Article ID 434830, 5 pages doi:10.1155/2012/434830 Clinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS Kim Forrester-Dumont,
More informationPCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS
PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women
More informationAnuja Dokras, MD., PhD. Professor Obstetrics and Gynecology Director PENN PCOS Center University of Pennsylvania, USA.
Anuja Dokras, MD., PhD. Professor Obstetrics and Gynecology Director PENN PCOS Center University of Pennsylvania, USA. Mood Disorders Based on the Diagnostic and Statistical Manual (DSM) V depressive disorders
More informationAEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y. V o l u m e 2, I s s u e 12 D E C E M B E R 3 1,
AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y D E C E M B E R 2 0 1 4 n e w s l e t t e r S M O K I N G I N W O M E N W I T H P C O S This issue newsletter reports the final program
More informationThoughts on PCOS Female Androgenization Syndrome FAS
Thoughts on PCOS Female Androgenization Syndrome FAS Stan Korenman, M.D. Distinguished Professor of Medicine-Endocrinology and Associate Dean - Ethics David Geffen School of Medicine at UCLA Conflicts
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationWHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED
WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED Ricardo Azziz, M.D., M.P.H., M.B.A. Chief Officer of Academic Health & Hospital Affairs State University of New York (SUNY)
More information12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman
Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society
More informationDetermining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)
Abstract: Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs) Ashraf Olabi, Ghena Alqotini College of medicine, Aleppo University Hospital Obstetrics and Gynacology, Syria.
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationAssisted Reproductive. Technologies: Present and. Future
Assisted Reproductive Technologies: Present and Future Paul Kaplan, M.D. The Assisted Reproductive Technologies (ART) In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (IVF/ICSI) Donor Oocyte
More informationPCOS guidelines: What s relevant to general practice
PCOS guidelines: What s relevant to general Dr David Molloy Medical Director, Queensland Fertility Group International evidence based PCOS guidelines 1st ever internationally endorsed & evidence based
More informationPregnancy outcome in women with polycystic ovary syndrome
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nivedhitha VS et al. Int J Reprod Contracept Obstet Gynecol. 2015 Aug;4(4):1169-1175 www.ijrcog.org pissn 2320-1770 eissn
More informationUNDERSTANDING PCOS AND ITS DIAGNOSIS
UNDERSTANDING PCOS AND ITS DIAGNOSIS Anuja Dokras MD, PhD Director PENN PCOS CENTER President, AE-PCOS Society Professor of Obstetrics & Gynecology University of Pennsylvania, Philadelphia, USA is an international
More informationEffect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome
FERTILITY AND STERILITY VOL. 71, NO. 2, FEBRUARY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effect of troglitazone
More informationPCOS. pregnancy complications. Prof. Bart CJM Fauser. Dept. Reproductive Medicine and Gynecology. University Medical Center, Utrecht, The Netherlands
PCOS pregnancy complications Prof. Bart CJM Fauser Dept. Reproductive Medicine and Gynecology University Medical Center, Utrecht, The Netherlands Disclosure of interest, Fauser Professor of Reproductive
More informationReproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationA REVIEW ON POLYCYSTIC OVARIAN SYNDROME AND ITS RELATION WITH THE METABOLIC SYNDROME
A REVIEW ON POLYCYSTIC OVARIAN SYNDROME AND ITS RELATION WITH THE METABOLIC SYNDROME Keziya Mary Philip 1, Krishnaveni K *1, Shanmugasundaram R 2, Sambathkumar R 3 1 Department of Pharmacy Practice, JKK
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationReproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)
Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Pr Sophie Christin-Maitre Reproductive Endocrine Unit, Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie INSERM U933 Paris, France
More informationAddressing Practice Gaps in PCOS
Addressing Practice Gaps in PCOS PCOS Challenge September 21, 2014 Ricardo Azziz, MD, MPH, MBA President, Georgia Regents University CEO, Georgia Regents Health System Introduction PCOS research began
More informationPrevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Choudhary A et al. Int J Reprod Contracept Obstet Gynecol. 2017 Nov;6(11):4971-4975 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175010
More informationUpdate on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
Update on PCOS Research Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Conflicts Consultant: Euroscreen, AstraZeneca, Ferring, Clarus, Kindex, Takeda Funding:
More informationInternational Journal of Clinical Endocrinology and Metabolism. Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
v Clinical Group International Journal of Clinical Endocrinology and Metabolism DOI CC By Rim Hanna 1 *, Tarek Wehbe 2 and Elizabeth Abou Jaoude 3 1 The Holy Spirit University of Kaslik, Faculty of Agricultural
More informationRisk of cardiovascular events in patients with polycystic ovary syndrome
ORIGINAL ARTICLE Risk of cardiovascular events in patients with polycystic ovary syndrome S. Iftikhar 1*, M.L. Collazo-Clavell 2, V.L. Roger 3, J. St. Sauver 4, R.D. Brown Jr 5, S. Cha 6, D.J. Rhodes 7
More informationNew PCOS guidelines: What s relevant to general practice
New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationPediatric Obesity: Clinical Decision Tools*
Pediatric Obesity: Clinical Decision Tools* Contributing clinicians from the Be Forever Fit Program at Harbor-UCLA in partnership with UniHealth Foundation: Gangadarshni Chandramohan, MD 1 ; Sudhir Anand,
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationGynecology & Reproductive Health
Research Article Gynecology & Reproductive Health ISSN 2639-9342 Combined Clomiphene Citrate-Metformin Versus Letrozole-Metformin in Achieving Pregnancy among Women with Polycystic Ovary Syndrome Shrivastava
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69 Effect of Metformin Only versus Effect of Metformin and Corticosteroids after Laparoscopic Ovarian Drilling on Ovulation
More informationPCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University
Reproductive Gynaecology and Infertility PCOS Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University Dr.Hussein Sabban MD. FRCSC PGY6 GREI Dalhousie University Disclosure No conflict of interest Pilot
More informationJannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP.
Jannet Huang, MD, FRCPC, FACE, ABIHM, CCD, NCMP. Polycystic Ovarian Syndrome Definition & Diagnosis Clinical Significance: Link to Diabetes and Cardiovascular Risk Management Lifestyle Strategies Pharmacologic
More informationOriginal Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?
Chettinad Health City Medical Journal Original Article Puvithra T*, Radha Pandiyan**, Pandiyan N*** *Assistant Professor, **Senior Consultant & Associate Professor, ***Prof & HOD, Department of Andrology
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationX/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.
0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Printed in U.S.A. Copyright 2006 by The Endocrine Society doi: 10.1210/jc.2005-1457 EXTENSIVE CLINICAL EXPERIENCE Relative
More informationEuropean Journal of Endocrinology (2006) ISSN
European Journal of Endocrinology (2006) 154 141 145 ISSN 0804-4643 CLINICAL STUDY Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence
More informationPrevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India
Original Article Prevalence of syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India Kavita Mandrelle, Mohan S Kamath, Dian J Bondu
More informationAmenorrhoea: polycystic ovary syndrome
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationMetabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
doi:10.1111/j.1447-0756.2007.00685.x J. Obstet. Gynaecol. Res. Vol. 34, No. 1: 62 66, February 2008 Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
More informationClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
POLYCYSTIC OVARY SYNDROME Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Ettore Guastella, M.D., a Rosa Alba Longo, M.D., b and Enrico Carmina, M.D. b a Department
More information13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH
13 th Annual Women s Health Day PCOS Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH Learning objectives Perform the appropriate investigations in women where there is a clinical suspicion
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More informationPrevalence of polycystic ovarian syndrome in the Buraimi region of Oman
Original Article Brunei Int Med J. 2012; 8 (5): 248-252 Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman Usha VARGHESE 1 and Shaji VARUGHESE 2, 1 Department of Internal Medicine
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome An Individualized Approach Alice Y. Chang, MD, MSc Assistant Professor Mayo Clinic Division of Endocrinology, Diabetes, Nutrition and Metabolism Learning Objectives: To Individualize
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationMetformin in early pregnancy and abortions. Laure Morin-Papunen, MD, PhD Dept. of Obstetrics and Gynecology University Hospital of Oulu, Finland
Metformin in early pregnancy and abortions Laure Morin-Papunen, MD, PhD Dept. of Obstetrics and Gynecology University Hospital of Oulu, Finland PCOS and miscarriage risk Metformin and miscarriage risk
More informationCan high serum anti-müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?
ORIGINAL ARTICLE http://dx.doi.org/1.5653/cerm.213.4.3.135 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 213;4(3):135-14 Can high serum anti-müllerian hormone levels predict the phenotypes of polycystic
More informationPolycystic Ovary Syndrome
International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com DOI: 10.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 7-2018 Research Article DOI: http://dx.doi.org/10.22192/ijarbs.2018.05.07.004
More informationThe Pharmacology of PCOS
The Pharmacology of PCOS G. Wright Bates, Jr., M.D. Director Reproductive Endocrinology & Infertility University of Alabama at Birmingham Objectives Review the diagnosis of PCOS Highlight lifestyle modifications
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More information13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, Hotel des Etrangers Passeggio Adorno 10/12, Siracusa, Italy
13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, 2015 Hotel des Etrangers Passeggio Adorno 10/12, 96100 Siracusa, Italy OCTOBER 4 th, 2015 Time Event/Speaker Topic 2:00 6:00 pm Registration 3:30
More informationPCOS & Diet Therapy. Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015
PCOS & Diet Therapy Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015 Questions to be discussed: 1) Why dietary modification is considered as first line of treatment? 2) What
More informationClinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40
Human Reproduction, Vol.26, No.12 pp. 3443 3449, 2011 Advanced Access publication on September 16, 2011 doi:10.1093/humrep/der302 ORIGINAL ARTICLE Reproductive endocrinology Clinical and biochemical presentation
More informationRichard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA
What have we learned from Multi-Clinical Trials in PCOS: Focus on Infertility Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Euroscreen,
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More informationAntim ullerian hormone and polycystic ovary syndrome
Antim ullerian hormone and polycystic ovary syndrome Yi-Hui Lin, M.D., a Wan-Chun Chiu, Ph.D., c Chien-Hua Wu, Ph.D., b,e Chii-Ruey Tzeng, M.D., d Chun-Sen Hsu, M.D., a and Ming-I Hsu, M.D. a a Department
More informationPOLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology
POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives Michel Abou Abdallah, MD. Reproductive Endocrinology At the conclusion of this presentation, participants should be able to: Appreciate the spectrum of
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More informationASSOCIATION OF INSULIN RESISTANCE AND SERUM 25 OH VITAMIN-D IN INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME
RESEARCH ARTICLE ASSOCIATION OF INSULIN RESISTANCE AND SERUM 25 OH VITAMIN-D IN INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME Amar Nagesh Kumar 1, Jupalle Nagaiah Naidu 2, Uppala Satyanarayana 3, Medabalmi
More informationDiagnosis and Management of PCOS
Diagnosis and Management of PCOS Anita L. Nelson, MD Professor Emeritus, Obstetrics & Gynecology, David Geffen School of Medicine at UCLA Clinical Professor Obstetrics & Gynecology, University Southern
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationRISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS)
RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS) N. A. Bagegni, BS 1, J Blaine, BS 1, B J VanVoorhis, MD 1, A Dokras, MD.PhD 2
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Kathleen Colleran, MD Professor of Medicine University of New Mexico HSC Presented for COMM-TC May 4, 2012 Objectives Understand the pathophysiology of PCOS Understand how to
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationPolycystic ovary syndrome in young women - new ideas
Polycystic ovary syndrome in young women - new ideas Disclosures Minor shareholder IVF clinic Grant support MSD, Merck and Ferring Grant support NHMRC Perspective is everything in PCOS Peacock s 2013 Polycystic
More informationThe Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS
JCEM ONLINE Brief Report Endocrine Research The Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS Meredith Brower, Kathleen Brennan, Marita Pall, and Ricardo Azziz Department
More informationPsychological impact of Polycystic Ovary Syndrome (PCOS)
Psychological impact of Polycystic Ovary Syndrome (PCOS) Dr Mandy Deeks PhD Psychologist Former Deputy CEO & Head of Translation, Education & Communication Unit Today: 5 things to ponder 1. PCOS is complex
More informationUpdate on Polycystic Ovary Syndrome What Dermatology Nurses and Nurse Practitioners Need to Know
FEATURE ARTICLE Update on Polycystic Ovary Syndrome What Dermatology Nurses and Nurse Practitioners Need to Know Rebecca Carron 2.0 Contact Hours ABSTRACT Purpose: Polycystic ovary syndrome is the most
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationBest Lipid Treatments
Best Lipid Treatments Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Overview of Talk Review of pathogenesis
More informationThe prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria
Prace oryginalne/original papers Endokrynologia Polska/Polish Journal of Endocrinology Tom/Volume 62; Numer/Number 3/2011 ISSN 0423 104X The prevalence of polycystic ovary syndrome in Iranian women based
More informationNo relevant financial relationships
MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu
More informationAEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y. V o l u m e 1, I s s u e 1 1. N o v e m b e r - D E C E M B E R,
AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y N OV E M B E R - D E C E M B E R n e w s l e t t e r 1 2 T H a n n u a l m e e t i n g o f a e p c o s s o c i e t y G l u c o s e
More information